Xu F, Li H, Jin T
Oncology Research Laboratory, The Toronto Hospital, University of Toronto, Toronto, Ontario M5G 2M1, Canada.
J Biol Chem. 1999 Nov 26;274(48):34310-6. doi: 10.1074/jbc.274.48.34310.
The caudal-related homeobox gene Cdx-2/3 is a critical "master" control gene in embryogenesis. Mice heterozygous for a null mutation in Cdx-2/3 exhibit multiple malfunctions including tail abnormalities, stunted growth, a homeotic shift in vertebrae, and the development of multiple intestinal adenomatous polyps, indicating that Cdx-2/3 is haplo-insufficient. In vitro studies have identified more than a half-dozen downstream target genes expressed in pancreatic and intestinal cells for this transcription factor. We have examined the transcriptional properties of the mouse Cdx-2/3 promoter. This promoter could be autoregulated in pancreatic and intestinal cells that express endogenous Cdx-2/3. In contrast, Cdx-2/3 transfection represses the Cdx-2/3 promoter in fibroblasts, which do not express endogenous Cdx-2/3. Since Cdx-2/3 activates proglucagon gene promoter in both pancreatic and intestinal cells and in fibroblasts, we suggest that some, yet to be identified, cell type-specific components are required for activating selected target gene promoters of Cdx-2/3, including the Cdx-2/3 promoter itself. Cdx-2/3 binds to the TATA box and another AT-rich motif, designated as DBS, within an evolutionarily conserved proximal element of the Cdx-2/3 promoter. The DBS motif is critical for the autoregulation, whereas the TATA box may act as an attenuating element for the autoregulatory loop. Finally, overexpression of Cdx-2/3 in a pancreatic cell line activated the expression of the endogenous Cdx-2/3. Taken together, our results indicate that the dose-dependent phenotype of Cdx-2/3 expression on its downstream targets in vivo could be regulated initially via a transcriptional network involving cell type-specific autoregulation of the Cdx-2/3 promoter.
尾相关同源框基因Cdx-2/3是胚胎发育过程中的关键“主”调控基因。Cdx-2/3基因无效突变的杂合子小鼠表现出多种功能异常,包括尾巴异常、生长发育迟缓、椎骨同源异型转变以及多发性肠腺瘤性息肉的形成,这表明Cdx-2/3基因单倍剂量不足。体外研究已经确定了该转录因子在胰腺和肠道细胞中表达的六个以上的下游靶基因。我们研究了小鼠Cdx-2/3启动子的转录特性。该启动子在表达内源性Cdx-2/3的胰腺和肠道细胞中可进行自我调节。相反,Cdx-2/3转染会抑制成纤维细胞中Cdx-2/3启动子的活性,而成纤维细胞不表达内源性Cdx-2/3。由于Cdx-2/3在胰腺和肠道细胞以及成纤维细胞中均可激活胰高血糖素原基因启动子,我们认为激活Cdx-2/3特定的靶基因启动子(包括Cdx-2/3启动子本身)需要一些尚未确定的细胞类型特异性成分。Cdx-2/3与Cdx-2/3启动子进化保守的近端元件内的TATA框和另一个富含AT的基序(称为DBS)结合。DBS基序对自我调节至关重要,而TATA框可能作为自我调节环的衰减元件。最后,胰腺细胞系中Cdx-2/3的过表达激活了内源性Cdx-2/3 的表达。综上所述,我们的结果表明,Cdx-2/3在体内对其下游靶标的剂量依赖性表型最初可能通过涉及Cdx-2/3启动子细胞类型特异性自我调节的转录网络进行调控。